HBM Partners

News

»	Devax receives CE Mark for the AXXESS drug eluting bifurcation stent
»	HBM BioVentures' largest public investment - Micrus - acquired by Johnson & Johnson
»	Lux Biosciences names Dean Mitchell President and CEO
»	Archive

M&A Report

»	HBM Pharma/Biotech M&A Report

Links

»	HBM BioVentures